Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Follicular thyroid cancer Stories

2012-06-11 20:35:05

Study finds that the majority of patients with thyroid cancer, except for those in the most advanced stage, continue to have the same chance of survival as those who are disease-free Research presented at the Society of Nuclear Medicine's 59th Annual Meeting reveals that patients with differentiated thyroid cancer live as long as people in perfect health, unless they are in the minority and have reached the most advanced stages of disease. Survival did not vary based on age, sex, or even...

2012-06-01 10:22:01

MADISON, N.J., June 1, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal. The test is believed to be the most comprehensive panel clinically available to identify mutations associated with four gene markers indicated by the American Thyroid Association for the clinical...

2011-11-10 09:00:00

SARASOTA, Fla., Nov. 10, 2011 /PRNewswire/ -- Amy Murray, a 35-year old mother of two, had a sore throat for weeks. When she begun to have trouble swallowing, she thought she might have strep throat, and went to see her doctor. He found a lump in her neck, and after several medical tests, Murray was diagnosed with papillary thyroid cancer. According to TMD Limited, a medical research company, Murray's research and ultimate decision to seek treatment outside of the US is typical of more...

2011-06-06 14:59:19

A mutant gene long thought to accelerate tumor growth in thyroid cancer patients actually inhibits the spread of malignant cells, showing promise for novel cancer therapies, a Mayo Clinic study has found. The findings will be presented by Mayo Clinic researcher Honey Reddi, Ph.D., at the Endocrine Society meeting in Boston. Dr. Reddi's discovery could have widespread implications in cancer research and endocrinology. It could help oncologists sharpen the diagnosis of specific types of thyroid...

2011-06-06 08:00:10

(Ivanhoe Newswire) -- Mayo Clinic researchers have found a mutant gene, which was long thought to accelerate tumor growth in thyroid cancer patients, actually inhibits the spread of cancerous cells. Thyroid cancer is the sixth most common cancer in the world. Between 15 percent and 20 percent of all thyroid cancers are follicular, which is a type that is more aggressive. Distinguishing between benign and malignant follicular thyroid cancer is often challenging for doctors because an accurate...

2010-09-22 09:51:39

(Ivanhoe Newswire) -- The results are in.  After a phase 2 trial, 49 percent of patients with advanced differentiated thyroid cancers responded to treatment using a drug designed to stop tumor blood vessel growth.  The name of drug that has shown the highest response of any treatment to date for advanced thyroid cancer: pazopanib.  The estimated time two-thirds of these patients are likely to have a response to the drug: 1 year or longer.  With the incidence of thyroid...

2009-05-18 12:21:00

ORLANDO, May 18 /PRNewswire-USNewswire/ -- A medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from Mayo Clinic indicates. At the annual meeting of the American Society of Clinical Oncology (ASCO), Mayo investigators report that cancer in about two-thirds of 37 patients with aggressive differentiated thyroid cancer treated with the drug pazopanib either stopped growing, or quickly shrank. The...

2005-06-23 18:50:00

COLUMBUS , Ohio "“ A blood test for thyroid cancer can detect persistent or recurrent disease even before doctors can find any trace of a tumor, according to a new study. The findings suggest that people treated for the disease should be examined regularly for early signs of recurrence. The study, by researchers at The Ohio State University Comprehensive Cancer Center "“ Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSU CCC "“ James), examined...